Conium Mac NDC 15631-2705

NDC codes

FDA NDC Directory

Product NDC (as listed)15631-2705Labeler and product segments. Claims need a package NDC.

Product NDC at billing width15631-2705Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
15631-2705-0	15631270500	10 mL in 1 BOTTLE (15631-2705-0)Marketed from May 23, 2024
15631-2705-1	15631270501	30 mL in 1 BOTTLE (15631-2705-1)Marketed from May 23, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Conium Mac
Generic name (nonproprietary): conium mac
Active ingredients: Conium maculatum flowering top — 3 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: May 23, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 15631-2705_1a0ae432-2cfa-16f8-e063-6294a90aefa0SPL ID 1a0ae432-2cfa-16f8-e063-6294a90aefa0SPL set ID 1a0ae432-2cf9-16f8-e063-6294a90aefa0UNII Q28R5GF371

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N415631270500 followed by a unit qualifier and the quantity

Package 15631-2705-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 4, 2024.

Indications (excerpt from the label)

INDICATIONS Condition listed above or as directed by the physician

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)